Free Trial

Aspen Aerogels, Inc. (NYSE:ASPN) Given Consensus Rating of "Moderate Buy" by Brokerages

Aspen Aerogels logo with Construction background

Key Points

  • Aspen Aerogels, Inc. has received an average rating of "Moderate Buy" from analysts, with an average 12-month price target of $18.375.
  • CEO Donald R. Young purchased 20,000 shares of the company at an average cost of $5.35 per share, increasing his ownership by 3.77%.
  • ASP stock is currently trading at $7.54, with a 12-month high of $33.15 and a low of $4.16.
  • Five stocks we like better than Aspen Aerogels.

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the ten research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $19.50.

Several equities research analysts recently commented on the stock. Oppenheimer lowered shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a report on Thursday, May 8th. Canaccord Genuity Group cut their price target on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a report on Friday. Finally, Barclays lowered shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and boosted their price target for the stock from $7.00 to $16.00 in a report on Monday.

View Our Latest Report on Aspen Aerogels

Institutional Investors Weigh In On Aspen Aerogels

Several institutional investors and hedge funds have recently added to or reduced their stakes in ASPN. Nisa Investment Advisors LLC boosted its stake in Aspen Aerogels by 1,094.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company's stock worth $28,000 after purchasing an additional 4,390 shares during the last quarter. SBI Securities Co. Ltd. boosted its stake in Aspen Aerogels by 67.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company's stock worth $38,000 after purchasing an additional 2,551 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in Aspen Aerogels during the 1st quarter worth $43,000. Banque Cantonale Vaudoise acquired a new stake in Aspen Aerogels during the 1st quarter worth $45,000. Finally, Exchange Traded Concepts LLC boosted its stake in Aspen Aerogels by 460.4% during the 1st quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock worth $48,000 after purchasing an additional 6,109 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Stock Performance

Shares of NYSE:ASPN traded up $0.49 during trading on Friday, hitting $7.44. 815,532 shares of the stock traded hands, compared to its average volume of 2,045,221. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The company has a market cap of $612.35 million, a price-to-earnings ratio of -1.95 and a beta of 2.73. The company has a fifty day moving average price of $6.75 and a two-hundred day moving average price of $7.00. Aspen Aerogels has a 52-week low of $4.16 and a 52-week high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.08. The firm had revenue of $78.02 million during the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The business's quarterly revenue was down 33.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.21 EPS. As a group, equities analysts predict that Aspen Aerogels will post 0.17 EPS for the current year.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines